Results 171 to 180 of about 697,104 (329)

Genetic Diversity of Plasmodium vivax Cysteine-Rich Protective Antigen (PvCyRPA) in Field Isolates from Five Different Areas of the Brazilian Amazon. [PDF]

Genes (Basel), 2021
Bitencourt Chaves L, Guimarães GO, Perce-da-Silva DS, Banic DM, Totino PRR, Machado RLD, Rodrigues-da-Silva RN, Pratt-Riccio LR, Daniel-Ribeiro CT, Lima-Junior JDC.   +9 more
europepmc   +1 more source

Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines. [PDF]

, 2015
Altmann, DM, Ascough, S, Baillie, L, Boyton, RJ, Doganay, M, Ingram, RJ, Maillere, B, Metan, G, Reynolds, CJ, Robinson, JH, Williamson, DE   +10 more
core   +1 more source

Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator

, 2013
Chunxue Lu, Bo Peng, Zhihong Li, Lei Lei, Zhongyu Li, Lili Chen, Qing‐zhi He, Guangming Zhong, Yimou Wu   +8 more
openalex   +1 more source

Bioengineered Pancreatic Cancer Immunosuppressive Microenvironment Models for Screening Immunotherapies

Advanced Healthcare Materials, EarlyView.
Bioengineering tumor‐stroma pancreatic cancer models with potential to emulate the native immunosuppressive tumor microenvironment. Cancer‐on‐a‐bead models exhibited higher relevance for screening immunotherapies and modulating the protumoral PDAC microenvironment. ABSTRACT Pancreatic cancer is notably resistant to treatment, primarily due to its dense
Maria V. Monteiro, Margarida Henriques‐Pereira, Bruno M. Neves, Vítor M. Gaspar, João F. Mano   +4 more
wiley   +1 more source

Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines. [PDF]

Poult Sci, 2021
Li Y, Rehman ZU, Li M, Manzoor Z, Liu W, Qiu X, Sun Y, Liao Y, Tan L, Song C, Liu W, Yu S, Ding C, Meng C.   +13 more
europepmc   +1 more source

Parasite Antigens in Protection, Diagnosis and Escape: Plasmodium

, 1985
In the hundred years since Laveran first described the malaria parasite as the cause of intermittent fevers, the basic biological questions posed at the end of his paper have been answered. The pathology of acute or chronic malaria infection is however still far from being fully understood and despite the accumulated knowledge of a century, the disease
openaire   +3 more sources

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway [PDF]

, 2004
Laurence Abrami, Margaret Lindsay, Robert G. Parton, Stephen H. Leppla, Gijs R. van den Brink   +4 more
openalex   +1 more source

Plasma‐Polymerized Nanoparticles Presenting Fibrillin‐1 Drive Rapid Re‐Endothelialization of Vascular Grafts

Advanced Healthcare Materials, EarlyView.
Commercial vascular grafts are made from ePTFE, a highly hydrophobic, foreign material that fails at a high rate in small‐diameter applications. Plasma polymer nanoparticles (PPN) are a versatile material functionalisation tool, used here to present fibrillin‐1 fragment PF8 on the graft surface.
Bob S. L. Lee, Yuen Ting Lam, Alex H. P. Chan, Praveesuda L. Michael, Timothy C. Mitchell, Jui Chien Hung, Miguel Santos, Khoon S. Lim, Richard P. Tan, Steven G. Wise   +9 more
wiley   +1 more source

Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans. [PDF]

Infect Immun, 2022
Mian SY, Somanathan A, Chaddha K, Pandey AK, Singh H, Krishna S, Chaturvedi N, Uchoi S, Shukla MM, Bharti PK, Singh N, Chauhan VS, Gaur D.   +12 more
europepmc   +1 more source